Clinical Trials

20 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07469592 2026-03-13

eHealth Mindfulness-based Music Therapy Intervention for Patients Undergoing Stem Cell Transplantation

LymphoidMyeloidOther hematologic neoplasm

165 enrolled

Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07178912 2026-03-09

Phase II Study of the Combination of Subcutaneous Blinatumomab and Olverembatinib in Patients With Philadelphia Chromosome (ph)-Positive and/or BCR::ABL1 Positive Acute Lymphoblastic Leukemia (ALL)

60 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07454226 2026-03-06

ABL/JAK Inhibitors With Chemotherapy and Venetoclax for Ph-like ALL

30 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07451743 2026-03-05

ACL ALL

100 enrolled

Phase 3 Not yet recruiting

Anterior Cruciate Ligament Injuries, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07223190 2026-03-04

AUDAX

560 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05565105 2026-03-03

CD34+ Transplants for Leukemia and Lymphoma

100 enrolled

Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07443592 2026-03-02

LAL-2025

330 enrolled

Phase 1 Not yet recruiting

Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07428486 2026-02-23

A Phase 1 Study Of FLAG Chemotherapy In Combination With Lisaftoclax And Pelcitoclax In Patients With Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia

24 enrolled

Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07008027 2026-02-19

Real World Asparaginase Therapy Toxicity

Not yet recruiting

200 enrolled

Leukemia, Biphenotypic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Drug-Related Side Effects and Adverse Reactions

NCT07374315 2026-02-12

Weight Gain in Pediatric Leukemia Survivors

LymphoidOtherOther hematologic neoplasm

80 enrolled

Leukemia, Health Behavior, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Pediatric Obesity

NCT06991920 2026-02-11

Immune-targeted Combination With Chemotherapy for Acute Leukemia of Ambiguous Lineage

50 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07313592 2026-02-09

Whole Genome Sequencing (ChromoSeq®) for Acute Lymphoblastic Leukemia (ALL) Patients

Not yet recruiting

60 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT07371403 2026-02-05

MB-CART19.1 in Relapsed/Refractory Acute Lymphoblastic Leukemia

12 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07228741 2026-02-04

Resistance Exercise and Incretin Mimetic for Cardiometabolic Health in Survivors of ALL With Obesity

LymphoidOtherOther hematologic neoplasm

20 enrolled

Obesity, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07387926 2026-02-04

Safety and Efficacy of Asciminib in Pediatrics and Young Adults With Relapse/Refractory (r/r) Philadelphia Positive (Ph+) or ABL-class Ph-like Acute Lymphoblastic Leukemia (ALL)

Phase 1/2 Not yet recruiting

50 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07371533 2026-01-28

A-319

18 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06739447 2026-01-23

Hospital Based Continuous Patient Monitoring System

250 enrolled

Wounds and Injuries, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07356960 2026-01-21

PONA4ALL Ph+

Not yet recruiting

103 enrolled

Phase 4 Not yet recruiting

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07320534 2026-01-08

Levofloxacin Prophylaxis to Prevent First Febrile Neutropenia in Pediatric ALL During Induction Phase

124 enrolled

Classical hematologyLymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma, Febrile Neutropenia

NCT07319481 2026-01-06

Preliminary Effectiveness and Feasibility of Transcutaneous Acupoints Electrical Stimulation on Chemotherapy-induced Peripheral Neuropathy Among Children With Acute Lymphoblastic Leukemia

60 enrolled

Phase 1 Not yet recruiting

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07166549 2025-12-24

BaseCAR-01

12 enrolled

Cytokine Release Syndrome, Lymphoma, Non-Hodgkin, Recurrence, Leukemia, B-Cell, Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07301138 2025-12-24

BEBT-908 Plus Chemotherapy Treatment for CR MRD-Positive MEF2D-Rearranged and Pre-B Acute Lymphoblastic Leukemia Patients

23 enrolled

Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07301424 2025-12-24

Subcutaneous Blinatumomab Plus Ponatinib for BCR-ABL+ B-ALL

80 enrolled

Phase 1 Not yet recruiting

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07283640 2025-12-22

A Phase IB Trial of Subcutaneous Blinatumomab in Combination With Revumenib for Patients With KMT2A-rearranged Acute Lymphoblastic Leukemia

20 enrolled